These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3512457

  • 1. Effects of cyclosporin A, antilymphocyte serum and donor-specific transfusions on murine delayed-type hypersensitivity and skin graft survival.
    Mottram PL, Mirisklavos A, Dumble LJ, Clunie GJ.
    Int Arch Allergy Appl Immunol; 1986; 79(3):296-304. PubMed ID: 3512457
    [Abstract] [Full Text] [Related]

  • 2. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
    De Fazio SR, Plowey JM, Hartner WC, Gozzo JJ.
    Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
    [Abstract] [Full Text] [Related]

  • 3. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR, Huang CW, Goto S, Wang CT, Hsu LW, Lin YC, Yang KD, Chen CL, Lee WP.
    J Surg Res; 2009 May 15; 153(2):317-25. PubMed ID: 19101689
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M, Lobo FM, Yamane Y, John L, Berger CL, Edelson RL.
    Ann N Y Acad Sci; 1991 Dec 30; 636():95-112. PubMed ID: 1793234
    [Abstract] [Full Text] [Related]

  • 5. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA, Gottschalk R, Maki T, Monaco AP.
    Transplantation; 1998 Feb 27; 65(4):473-9. PubMed ID: 9500619
    [Abstract] [Full Text] [Related]

  • 6. T suppressor cells induced by transfusions and cyclosporine. Studies in the murine cardiac allograft model.
    Mottram PL, Mirisklavos A, Dumble LJ, Clunie GJ.
    Transplantation; 1990 Dec 27; 50(6):1033-7. PubMed ID: 2147790
    [Abstract] [Full Text] [Related]

  • 7. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H, Monaco AP.
    Transplantation; 1992 Dec 27; 54(6):1090-5. PubMed ID: 1465774
    [Abstract] [Full Text] [Related]

  • 8. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD, Morris RE.
    Transplantation; 1993 Mar 27; 55(3):578-91. PubMed ID: 7681226
    [Abstract] [Full Text] [Related]

  • 9. Induction of allograft tolerance with neonatal skin.
    Jamshidi F, De Fazio SR, Markees TG, Gozzo JJ.
    Transplantation; 1991 May 27; 51(5):1048-52. PubMed ID: 2031261
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
    Perez M, Edelson R, Laroche L, Berger C.
    J Invest Dermatol; 1989 May 27; 92(5):669-76. PubMed ID: 2523941
    [Abstract] [Full Text] [Related]

  • 11. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
    Jamshidi F, De Fazio SR, Gozzo JJ.
    Transplantation; 1993 Jul 27; 56(1):135-8. PubMed ID: 8333035
    [Abstract] [Full Text] [Related]

  • 12. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA, Gottschalk R, Fukuzaki T, Wood ML, Maki T, Monaco AP.
    Transplantation; 1997 Feb 15; 63(3):359-64. PubMed ID: 9039923
    [Abstract] [Full Text] [Related]

  • 13. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T, Hancock WW, Monaco AP, Maki T.
    Transplantation; 1998 Apr 27; 65(8):1036-43. PubMed ID: 9583862
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts.
    Mottram PL, Mirisklavos A, Clunie GJ.
    Transplant Proc; 1985 Apr 27; 17(2):1646-9. PubMed ID: 3885498
    [No Abstract] [Full Text] [Related]

  • 16. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF.
    Transplantation; 1998 Oct 27; 66(8):1059-66. PubMed ID: 9808492
    [Abstract] [Full Text] [Related]

  • 17. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK, Pepose JS, Stuart PM.
    Invest Ophthalmol Vis Sci; 1995 Jul 27; 36(8):1530-40. PubMed ID: 7601633
    [Abstract] [Full Text] [Related]

  • 18. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC, Markees TG, De Fazio SR, Khouri W, Maki T, Monaco AP, Gozzo JJ.
    Transplantation; 1991 Nov 27; 52(5):784-9. PubMed ID: 1835194
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
    Perez MI, Edelson RL, John L, Laroche L, Berger CL.
    Yale J Biol Med; 1989 Nov 27; 62(6):595-609. PubMed ID: 2636801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.